在导管切除后的巨型右心房瘤
Takeshi Wada1, Hirotsugu Hamamoto2, Shinji Miyamoto3
1Department of Cardiovascular Surgery, Almeida Memorial Hospital, 1509-2, Miyazaki, Oita, Oita, 870-1195, Japan. wa.22.ta@gmail.com.
General Thoracic and Cardiovascular Surgery Cases
|November 9, 2024
概括
一个罕见的巨型右心房髓瘤被发现在一个患者三年后的导管切除. 这一案例表明心脏手术和肌瘤发展之间存在潜在联系,需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 在瘤学瘤学.
背景情况:
- 这是一个罕见的巨型右心房髓瘤病例.
- 瘤是在激光导管切除后三年被发现的.
研究的目的:
- 报告一个罕见的心脏神经瘤在导管切除后的病例.
- 讨论导管切除与肌瘤发展之间的潜在关联.
主要方法:
- 一名74岁的男性出现了源不明的发烧.
- 多式成像检查发现了一个大右心房瘤.
- 手术切除和病理检查证实了myxoma.
主要成果:
- 一个巨大的右心房肌瘤成功切除.
- 病理学检查证实瘤是一种瘤.
结论:
- 心脏肌瘤的发展可能与导管切除有关.
- 导管切除造成的组织损伤可能会引发瘤的形成.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
2.2K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.2K
Cardiac Catheterization III: Left Heart Catheterization
1.3K
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812


